Halozyme Therapeutics HALO Income Statements

Conto economico

Quarter End	Mar 2022	Giu 2022	Set 2022	Dic 2022	Mar 2023	Giu 2023	Set 2023	Dic 2023
	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)
Entrate totali	117,28M	152,37M	208,98M	181,5M	162,14M	221,04M	216,03M	230,04M
Reddito operativo	75,67M	34,06M	63,19M	74,51M	53,8M	94,46M	88,28M	101,04M
Reddito ante imposte	74,41M	30,01M	73,71M	70,79M	52,24M	93,16M	101,76M	101,18M
Reddito netto	60,11M	22,69M	61,63M	57,7M	39,62M	74,75M	81,84M	85,39M
Dividendi preferiti	0	0	0	0	0	0	0	0
Utile base per azione (EPS)	0	0	0	0	0	0	0	0
UTILE OPERATIVO	76,17M	33,61M	60,93M	74,51M	53,8M	94,46M	88,28M	101,04M
EBITDA	76,45M	46,61M	92,4M	81,62M	74,26M	115,09M	111,36M	121,73M

Fine anno 31 Dicembre 2023	2016	2017	2018	2019	2020	2021	2022	2023
	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)
Entrate totali	146,69M	316,61M	151,86M	195,99M	267,59M	443,31M	660,12M	829,25M
Reddito operativo	-83,21M	81M	-69,33M	-67,61M	144,26M	275,9M	267,53M	337,57M
Reddito ante imposte	-101,86M	61,61M	-79,79M	-72,25M	129,3M	248,52M	248,92M	348,33M
Reddito netto	-103,02M	62,97M	-80,33M	-72,24M	129,09M	402,71M	202,13M	281,59M
Dividendi preferiti	0	0	0	0	0	0	0	0
Utile base per azione (EPS)	-0.748	0.417	-0.525	-0.499	0.901	2.764	1.41	2.007
UTILE OPERATIVO	-83,21M	81M	-61,75M	-60,62M	149,68M	254,94M	264,82M	337,57M
EBITDA	-80,8M	83,16M	-66,94M	-63,54M	147,54M	278,9M	317,17M	422,43M